FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110733906> ?p ?o ?g. }

• W2110733906 endingPage "1507" @default.
• W2110733906 startingPage "1504" @default.
• W2110733906 abstract "No AccessJournal of UrologyCLINICAL UROLOGY: Original Articles1 Apr 2004RACIAL/ETHNIC DISPARITIES IN THE TREATMENT OF LOCALIZED/REGIONAL PROSTATE CANCERis corrected byRE: RACIAL/ETHNIC DISPARITIES IN THE TREATMENT OF LOCALIZED/REGIONAL PROSTATE CANCERRE: RACIAL/ETHNIC DISPARITIES IN THE TREATMENT OF LOCALIZED/REGIONAL PROSTATE CANCER WILLIE UNDERWOOD, SONYA DeMONNER, PETER UBEL, ANGELA FAGERLIN, MARTIN G. SANDA, and JOHN T. WEI WILLIE UNDERWOODWILLIE UNDERWOOD More articles by this author , SONYA DeMONNERSONYA DeMONNER More articles by this author , PETER UBELPETER UBEL More articles by this author , ANGELA FAGERLINANGELA FAGERLIN More articles by this author , MARTIN G. SANDAMARTIN G. SANDA More articles by this author , and JOHN T. WEIJOHN T. WEI More articles by this author View All Author Informationhttps://doi.org/10.1097/01.ju.0000118907.64125.e0AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: Racial/ethnic disparities in the utilization of definitive therapy for prostate cancer are well recognized in the United States. The effect of race on the use of contemporary definitive therapies, including brachytherapy, and the assessment of Hispanic men with regard to racial/ethnic disparity has not been fully characterized. Materials and Methods: We evaluated treatment patterns using Surveillance, Epidemiology and End Results registry data on 142,340 localized/regional stage cases between 1992 and 1999 in white, black and Hispanic American men. Definitive therapy was defined as radical prostatectomy, external beam radiation, brachytherapy or combinations thereof. Logistic regression models were constructed to determine the odds of receiving definitive treatment, adjusting for age, marital status, tumor grade, and Surveillance, Epidemiology and End Results site. Results: Black and Hispanic men were less likely to receive definitive therapy than white men (p <0.001). Higher tumor grade was associated with decreasing odds of definitive therapy for black and Hispanic men (p <0.001) compared to white men. The racial/ethnic disparities in the use of definitive therapy decreased between 1992 and 1999 with the greatest decrease in Hispanic men. Conclusions: Hispanic and black men were less likely than white men to receive definitive therapy. The disparity in the use of definitive therapy between 1992 and 1999 decreased significantly in Hispanic men, although a significant disparity in the use of definitive therapy persisted in black men. Our observation of an association between tumor grade and the racial/ethnic disparity in definitive therapy ties together relevant biological and social factors that may contribute to the observed racial/ethnic disparity in mortality. References 1 : Cancer statistics, 2003. CA Cancer J Clin2003; 53: 5. Google Scholar 2 : Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987. Urology1995; 45: 93. Crossref, Medline, Google Scholar 3 : Treatment of localized prostate cancer in African-American compared with Caucasian men. Less use of aggressive therapy for comparable disease. Med Care1995; 33: 1079. Google Scholar 4 : Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate. J Clin Oncol1995; 13: 93. Google Scholar 5 : Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J Natl Cancer Inst2001; 93: 1864. Google Scholar 6 : A successful recruitment process of African American men for early detection of prostate cancer. Cancer1995; 75: 1880. Google Scholar 7 : Available at. http://eire.census.gov/popest/archives/national/nationa3.php. Accessed April 2, 2002. Google Scholar 8 : Trends in the survival of American Indian, Hispanic, and Non-Hispanic white cancer patients in New Mexico and Arizona, 1969–1994. Cancer1998; 82: 1769. Google Scholar 9 : The National Cancer Data Base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S. Cancer1999; 86: 1877. Google Scholar 10 SEER Program Code Manual. Bethesda, Maryland: National Cancer Institute1998. Google Scholar 11 : The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev1999; 8: 1117. Google Scholar 12 : Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA1998; 280: 975. Crossref, Medline, Google Scholar 13 : Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA1995; 274: 1599. Crossref, Medline, Google Scholar 14 : Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1–T2 prostate cancer. J Urol2000; 163: 143. Link, Google Scholar 15 : Survival of blacks and whites after a cancer diagnosis. JAMA2002; 287: 2106. Google Scholar 16 : Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA. Lancet1999; 354: 975. Google Scholar 17 : Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. J Natl Cancer Inst2000; 92: 2009. Google Scholar 18 : Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA2000; 283: 3217. Google Scholar 19 : Racial disparity in cardiac decision making: results from patient focus groups. Arch Intern Med1998; 158: 1450. Google Scholar 20 : Comparison of methods for classifying Hispanic ethnicity in a population-based cancer registry. Am J Epidemiol1999; 149: 1063. Google Scholar From the Robert Wood Johnson Clinical Scholars Program (WU, SD), Division of Clinical Research and Quality Assurance, Department of Urology (WU, MGS, JTW) and Program for Improving Health Care Decisions, Division of General Medicine (PU, AF), University of Michigan, Veterans Affairs Center for Practice Management and Outcomes Research (WU, SD, PU, AF) and Veteran Administration Healthcare System (PU, AF), Ann Arbor, Michigan© 2004 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byChhatre S, Malkowicz S, Gallo J and Jayadevappa R (2023) Racial Disparity in Outcomes Among Prostate Cancer Patients in the Post–Affordable Care Act PeriodUrology Practice, VOL. 10, NO. 2, (123-129), Online publication date: 1-Mar-2023.DeWitt-Foy M, Gam K, Modlin C, Kim S and Abouassaly R (2020) Race, Decisional Regret and Prostate Cancer Beliefs: Identifying Targets to Reduce Racial Disparities in Prostate CancerJournal of Urology, VOL. 205, NO. 2, (426-433), Online publication date: 1-Feb-2021.Webster B, Riley J and Davis M (2020) Initial Presentation and Outcomes of Testicular Cancer among Different Racial and Ethnic Groups at a Tertiary Care Facility in New MexicoUrology Practice, VOL. 8, NO. 1, (71-77), Online publication date: 1-Jan-2021.Krimphove M, Fletcher S, Cole A, Berg S, Sun M, Lipsitz S, Mahal B, Nguyen P, Choueiri T, Kibel A, Kluth L, Weissman J and Trinh Q (2018) Quality of Care in the Treatment of Localized Intermediate and High Risk Prostate Cancer at Minority Serving HospitalsJournal of Urology, VOL. 201, NO. 4, (735-741), Online publication date: 1-Apr-2019.Taneja S (2016) Re: Racial Differences in the Surgical Care of Medicare Beneficiaries with Localized Prostate CancerJournal of Urology, VOL. 196, NO. 3, (742-743), Online publication date: 1-Sep-2016.Kelly S, Van Den Eeden S, Hoffman R, Aaronson D, Lobo T, Luta G, Leimpter A, Shan J, Potosky A and Taylor K (2016) Sociodemographic and Clinical Predictors of Switching to Active Treatment among a Large, Ethnically Diverse Cohort of Men with Low Risk Prostate Cancer on Observational ManagementJournal of Urology, VOL. 196, NO. 3, (734-740), Online publication date: 1-Sep-2016.Mahmood U, Levy L, Nguyen P, Lee A, Kuban D and Hoffman K (2014) Current Clinical Presentation and Treatment of Localized Prostate Cancer in the United StatesJournal of Urology, VOL. 192, NO. 6, (1650-1656), Online publication date: 1-Dec-2014.Filson C, Schroeck F, Ye Z, Wei J, Hollenbeck B and Miller D (2014) Variation in Use of Active Surveillance among Men Undergoing Expectant Treatment for Early Stage Prostate CancerJournal of Urology, VOL. 192, NO. 1, (75-81), Online publication date: 1-Jul-2014.Holmes J, Carpenter W, Wu Y, Hendrix L, Peacock S, Massing M, Schenck A, Meyer A, Diao K, Wheeler S, Godley P, Stitzenberg K and Chen R (2012) Impact of Distance to a Urologist on Early Diagnosis of Prostate Cancer Among Black and White PatientsJournal of Urology, VOL. 187, NO. 3, (883-888), Online publication date: 1-Mar-2012.Powell I, Bock C, Ruterbusch J and Sakr W (2010) Evidence Supports a Faster Growth Rate and/or Earlier Transformation to Clinically Significant Prostate Cancer in Black Than in White American Men, and Influences Racial Progression and Mortality DisparityJournal of Urology, VOL. 183, NO. 5, (1792-1797), Online publication date: 1-May-2010.Abraham N, Wan F, Montagnet C, Wong Y and Armstrong K (2007) Decrease in Racial Disparities in the Staging Evaluation for Prostate Cancer After Publication of Staging GuidelinesJournal of Urology, VOL. 178, NO. 1, (82-87), Online publication date: 1-Jul-2007.Ramsey S, Zeliadt S, Hall I, Ekwueme D and Penson D (2018) On the Importance of Race, Socioeconomic Status and Comorbidity When Evaluating Quality of Life in Men With Prostate CancerJournal of Urology, VOL. 177, NO. 6, (1992-1999), Online publication date: 1-Jun-2007.McFall S (2018) Use and Awareness of Prostate Specific Antigen Tests and Race/EthnicityJournal of Urology, VOL. 177, NO. 4, (1475-1480), Online publication date: 1-Apr-2007.Powell I (2018) Epidemiology and Pathophysiology of Prostate Cancer in African-American MenJournal of Urology, VOL. 177, NO. 2, (444-449), Online publication date: 1-Feb-2007.Lee C, Dunn R, Williams C and Underwood W (2018) Racial Disparity in Bladder Cancer: Trends in Tumor Presentation at DiagnosisJournal of Urology, VOL. 176, NO. 3, (927-934), Online publication date: 1-Sep-2006.NELSON C, PARK J, DUNN R and WEI J (2018) CONTEMPORARY TRENDS IN SURGICAL CORRECTION OF PEDIATRIC URETEROPELVIC JUNCTION OBSTRUCTION: DATA FROM THE NATIONWIDE INPATIENT SAMPLEJournal of Urology, VOL. 173, NO. 1, (232-236), Online publication date: 1-Jan-2005.Related articlesJournal of Urology9 Nov 2018RE: RACIAL/ETHNIC DISPARITIES IN THE TREATMENT OF LOCALIZED/REGIONAL PROSTATE CANCERJournal of Urology9 Nov 2018RE: RACIAL/ETHNIC DISPARITIES IN THE TREATMENT OF LOCALIZED/REGIONAL PROSTATE CANCER Volume 171Issue 4April 2004Page: 1504-1507 Advertisement Copyright & Permissions© 2004 by American Urological Association, Inc.KeywordsAfrican continental ancestry groupprostateEuropean continental ancestry groupprostatic neoplasmsHispanic AmericansMetricsAuthor Information WILLIE UNDERWOOD More articles by this author SONYA DeMONNER More articles by this author PETER UBEL More articles by this author ANGELA FAGERLIN More articles by this author MARTIN G. SANDA More articles by this author JOHN T. WEI More articles by this author Expand All Advertisement PDF downloadLoading ..." @default.
• W2110733906 created "2016-06-24" @default.
• W2110733906 creator A5002476840 @default.
• W2110733906 creator A5004417664 @default.
• W2110733906 creator A5008438184 @default.
• W2110733906 creator A5041355589 @default.
• W2110733906 creator A5064561416 @default.
• W2110733906 creator A5069680858 @default.
• W2110733906 date "2004-04-01" @default.
• W2110733906 modified "2023-09-29" @default.
• W2110733906 title "RACIAL/ETHNIC DISPARITIES IN THE TREATMENT OF LOCALIZED/REGIONAL PROSTATE CANCER" @default.
• W2110733906 cites W1900085717 @default.
• W2110733906 cites W1974568152 @default.
• W2110733906 cites W2016426829 @default.
• W2110733906 cites W2016725888 @default.
• W2110733906 cites W2022771893 @default.
• W2110733906 cites W2030336968 @default.
• W2110733906 cites W2054004588 @default.
• W2110733906 cites W2069272665 @default.
• W2110733906 cites W2072877502 @default.
• W2110733906 cites W2109694492 @default.
• W2110733906 cites W2112281431 @default.
• W2110733906 cites W2113868668 @default.
• W2110733906 cites W2125972393 @default.
• W2110733906 cites W2145231286 @default.
• W2110733906 cites W2156776019 @default.
• W2110733906 cites W4232042670 @default.
• W2110733906 cites W4240305414 @default.
• W2110733906 doi "https://doi.org/10.1097/01.ju.0000118907.64125.e0" @default.
• W2110733906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15017208" @default.
• W2110733906 hasPublicationYear "2004" @default.
• W2110733906 type Work @default.
• W2110733906 sameAs 2110733906 @default.
• W2110733906 citedByCount "138" @default.
• W2110733906 countsByYear W21107339062012 @default.
• W2110733906 countsByYear W21107339062013 @default.
• W2110733906 countsByYear W21107339062014 @default.
• W2110733906 countsByYear W21107339062015 @default.
• W2110733906 countsByYear W21107339062016 @default.
• W2110733906 countsByYear W21107339062017 @default.
• W2110733906 countsByYear W21107339062018 @default.
• W2110733906 countsByYear W21107339062019 @default.
• W2110733906 countsByYear W21107339062020 @default.
• W2110733906 countsByYear W21107339062021 @default.
• W2110733906 countsByYear W21107339062022 @default.
• W2110733906 countsByYear W21107339062023 @default.
• W2110733906 crossrefType "journal-article" @default.
• W2110733906 hasAuthorship W2110733906A5002476840 @default.
• W2110733906 hasAuthorship W2110733906A5004417664 @default.
• W2110733906 hasAuthorship W2110733906A5008438184 @default.
• W2110733906 hasAuthorship W2110733906A5041355589 @default.
• W2110733906 hasAuthorship W2110733906A5064561416 @default.
• W2110733906 hasAuthorship W2110733906A5069680858 @default.
• W2110733906 hasConcept C121608353 @default.
• W2110733906 hasConcept C126322002 @default.
• W2110733906 hasConcept C137403100 @default.
• W2110733906 hasConcept C143998085 @default.
• W2110733906 hasConcept C144024400 @default.
• W2110733906 hasConcept C19165224 @default.
• W2110733906 hasConcept C2780192828 @default.
• W2110733906 hasConcept C71924100 @default.
• W2110733906 hasConceptScore W2110733906C121608353 @default.
• W2110733906 hasConceptScore W2110733906C126322002 @default.
• W2110733906 hasConceptScore W2110733906C137403100 @default.
• W2110733906 hasConceptScore W2110733906C143998085 @default.
• W2110733906 hasConceptScore W2110733906C144024400 @default.
• W2110733906 hasConceptScore W2110733906C19165224 @default.
• W2110733906 hasConceptScore W2110733906C2780192828 @default.
• W2110733906 hasConceptScore W2110733906C71924100 @default.
• W2110733906 hasIssue "4" @default.
• W2110733906 hasLocation W21107339061 @default.
• W2110733906 hasLocation W21107339062 @default.
• W2110733906 hasOpenAccess W2110733906 @default.
• W2110733906 hasPrimaryLocation W21107339061 @default.
• W2110733906 hasRelatedWork W1980245127 @default.
• W2110733906 hasRelatedWork W2045770655 @default.
• W2110733906 hasRelatedWork W2221425694 @default.
• W2110733906 hasRelatedWork W2486716385 @default.
• W2110733906 hasRelatedWork W2810602217 @default.
• W2110733906 hasRelatedWork W2908318037 @default.
• W2110733906 hasRelatedWork W2915965072 @default.
• W2110733906 hasRelatedWork W2962601203 @default.
• W2110733906 hasRelatedWork W2189427681 @default.
• W2110733906 hasRelatedWork W2530851007 @default.
• W2110733906 hasVolume "171" @default.
• W2110733906 isParatext "false" @default.
• W2110733906 isRetracted "false" @default.
• W2110733906 magId "2110733906" @default.
• W2110733906 workType "article" @default.